Skip to main content
UniHealth

Doctor search

Ying Zhu, MD

Hematology/Oncology · Santa Clara

NPI 1568550457

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
4
1 carrier
Offices
2

Offices

2 locations · Permanente Medical Group Inc · 10,928 clinicians in this group

Looking this up.

Plans that list them

4 plans · 1 carrier

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Zhu’s office at (408) 851-1000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

Plans whose provider directory lists this clinician
Kaiser Permanente Dual Complete North P2 (HMO D-SNP)Kaiser PermanenteListedSep 1, 2026
Kaiser Permanente Dual Complete North P23 (HMO D-SNP)Kaiser PermanenteListedSep 1, 2026
Kaiser Permanente Sr Adv Basic Santa Clara (HMO)Kaiser PermanenteListedSep 1, 2026
Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO)Kaiser PermanenteListedSep 1, 2026

Drugs they prescribed that Part D paid

$2,756,581

Pharmacies billed $2,756,581 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 13% of their Part D prescriptions (79 of 634) in 2024. Above the middle of the specialty; the typical hematology-oncology clinician is at 5%.

447 generic and 187 brand-name prescriptions · $2,756,581 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Lenvima22$457,161$20,780
Pomalyst18$450,365$25,020
Lynparza30$418,124$13,937
Tavalisse25$371,729$14,869
Lenalidomide20$269,610$13,481
See all 22 drugs
Every Part D drug this clinician prescribed
Lenvima22$457,161$20,780
Pomalyst18$450,365$25,020
Lynparza30$418,124$13,937
Tavalisse25$371,729$14,869
Lenalidomide20$269,610$13,481
Tagrisso11$188,753$17,159
Xermelo13$125,941$9,688
Brukinsa12$79,085$6,590
Venclexta15$67,766$4,518
Hydroxyurea59$2,821$48
Imatinib Mesylate22$2,390$109
Hydrocodone-Acetaminophen76$1,651$22
Dexamethasone Sodium Phosphate17$692$41
Letrozole24$491$20
Dexamethasone18$453$25
Acyclovir16$446$28
Lorazepam28$421$15
Anastrozole13$364$28
Gabapentin12$235$20
Ondansetron15$224$15
Temazepam16$183$11
Zolpidem14$95$7

Year by year

Part D prescribing by year
20246349913% (79)29%$2,756,581
202369011116% (110)None$2,770,916
202259111214% (82)25%$1,894,019
202151411610% (52)None$1,743,678
202049611311% (52)None$2,029,447
201945711013% (60)None$1,293,664
201839511711% (45)24%$1,079,544
201761312412% (76)28%$1,338,289
201647012210% (46)19%$624,654
201548511710% (46)18%$557,782
201446912011% (50)14%$207,452
201346211716% (74)None$173,457

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 23 drugs

Part D drugs prescribed in 2023
Pomalyst23$529,650$23,028
Lenalidomide32$444,848$13,902
Lynparza27$355,941$13,183
Promacta27$334,024$12,371
Tavalisse17$254,303$14,959
Gleevec11$202,277$18,389
Tagrisso12$197,920$16,493
Xermelo12$105,783$8,815
Venclexta12$46,873$3,906
Hydroxyurea63$2,872$46
Hydrocodone-Acetaminophen85$1,207$14
Imatinib Mesylate12$1,039$87
Dexamethasone18$883$49
Acyclovir21$760$36
Anastrozole17$438$26
Gabapentin16$425$27
Letrozole17$319$19
Lorazepam34$287$8
Prednisone17$221$13
Ondansetron17$208$12
Oxycodone-Acetaminophen11$128$12
Zolpidem16$110$7
Oxycodone12$105$9

2022: 17 drugs

Part D drugs prescribed in 2022
Tavalisse23$322,072$14,003
Lynparza24$274,062$11,419
Gleevec12$220,666$18,389
Promacta15$162,599$10,840
Xermelo13$104,456$8,035
Hydroxyurea57$3,416$60
Dexamethasone32$1,956$61
Hydrocodone-Acetaminophen71$1,142$16
Imatinib Mesylate12$1,089$91
Acyclovir19$711$37
Gabapentin12$476$40
Letrozole18$382$21
Anastrozole14$345$25
Lorazepam26$233$9
Prednisone15$195$13
Ondansetron13$185$14
Zolpidem16$107$7

2021: 14 drugs

Part D drugs prescribed in 2021
Pomalyst31$639,335$20,624
Lynparza31$356,535$11,501
Gleevec12$220,666$18,389
Xermelo12$90,845$7,570
Hydroxyurea61$4,037$66
Dexamethasone16$1,200$75
Anastrozole25$794$32
Hydrocodone-Acetaminophen44$790$18
Gabapentin17$763$45
Acyclovir14$711$51
Letrozole15$365$24
Ondansetron20$292$15
Lorazepam14$117$8
Temazepam11$116$11

2020: 13 drugs

Part D drugs prescribed in 2020
Lynparza54$686,454$12,712
Pomalyst18$344,902$19,161
Gleevec13$239,055$18,389
Alecensa11$208,065$18,915
Hydroxyurea50$2,881$58
Dexamethasone14$1,400$100
Gabapentin20$911$46
Hydrocodone-Acetaminophen48$847$18
Anastrozole29$697$24
Acyclovir14$554$40
Letrozole13$291$22
Ondansetron12$148$12
Lorazepam12$96$8

2019: 15 drugs

Part D drugs prescribed in 2019
Pomalyst13$231,536$17,810
Ibrance15$221,803$14,787
Revlimid13$184,231$14,172
Imbruvica11$108,005$9,819
Exemestane13$3,955$304
Hydroxyurea41$2,516$61
Dexamethasone23$2,274$99
Acyclovir31$943$30
Anastrozole27$664$25
Hydrocodone-Acetaminophen50$645$13
Gabapentin12$503$42
Allopurinol14$323$23
Lorazepam16$142$9
Zolpidem11$107$10
Trazodone14$98$7

2018: 9 drugs

Part D drugs prescribed in 2018
Revlimid25$374,912$14,996
Imbruvica13$131,432$10,110
Hydroxyurea34$2,814$83
Dexamethasone21$1,524$73
Anastrozole32$852$27
Acyclovir22$711$32
Hydrocodone-Acetaminophen37$530$14
Prochlorperazine Maleate16$170$11
Lorazepam15$128$9

2017: 22 drugs

Part D drugs prescribed in 2017
Revlimid34$404,050$11,884
Ibrance18$214,725$11,929
Imbruvica15$173,186$11,546
Votrient11$127,716$11,611
Lovenox39$18,308$469
Hydroxyurea38$3,970$104
Pradaxa13$2,869$221
Anastrozole47$1,363$29
Acyclovir33$1,150$35
Hydrocodone-Acetaminophen37$968$26
Fentanyl11$775$70
Dexamethasone21$472$22
Azathioprine12$416$35
Letrozole12$325$27
Prednisone14$235$17
Prochlorperazine Maleate21$215$10
Venlafaxine12$205$17
Oxycodone12$197$16
Ondansetron13$162$12
Zolpidem13$135$10
Temazepam11$116$11
Lorazepam13$112$9

2016: 12 drugs

Part D drugs prescribed in 2016
Revlimid21$235,853$11,231
Gleevec13$155,518$11,963
Lovenox14$8,574$612
Hydroxyurea37$3,485$94
Anastrozole71$2,455$35
Acyclovir30$1,388$46
Hydrocodone-Acetaminophen32$1,158$36
Gabapentin14$1,096$78
Tamoxifen Citrate11$619$56
Prochlorperazine Maleate31$354$11
Venlafaxine13$156$12
Trazodone15$126$8

2015: 11 drugs

Part D drugs prescribed in 2015
Imbruvica15$135,874$9,058
Tarceva14$90,756$6,483
Hydroxyurea33$3,406$103
Anastrozole89$2,875$32
Acyclovir35$1,771$51
Hydrocodone-Acetaminophen33$1,473$45
Megestrol Acetate12$934$78
Allopurinol11$392$36
Venlafaxine13$218$17
Prochlorperazine Maleate13$163$13
Trazodone13$98$8

2014: 11 drugs

Part D drugs prescribed in 2014
Tarceva16$105,081$6,568
Lovenox12$8,858$738
Anastrozole122$4,286$35
Hydroxyurea31$2,458$79
Acyclovir18$871$48
Hydrocodone-Acetaminophen30$587$20
Venlafaxine12$503$42
Prednisone12$322$27
Prochlorperazine Maleate21$261$12
Sulfamethoxazole-Trimethoprim14$174$12
Lorazepam15$129$9

2013: 7 drugs

Part D drugs prescribed in 2013
Revlimid13$120,322$9,256
Anastrozole135$5,488$41
Hydroxyurea21$2,617$125
Hydrocodone-Acetaminophen35$596$17
Venlafaxine12$503$42
Prochlorperazine Maleate11$126$11
Lorazepam11$114$10

Money from drug and device companies

$30 in 2025

Industry payments by year
202511None$30
202411None$21
202322None$39

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
BeOne Medicines USABrukinsa$30
1 payment
  • Meals for Brukinsa · 2025-07-11 · $30
See the published payment
Every published payment
BeOne Medicines USAMeals · 2025-07-11Brukinsa$30
See earlier years (2024, 2023)

2024: $21

Payments by company in 2024
Novartis PharmaceuticalsKisqali$21
1 payment
  • Meals for Kisqali · 2024-04-24 · $21

2023: $39

Payments by company in 2023
Novartis PharmaceuticalsPiqray$21
1 payment
  • Meals for Piqray · 2023-10-06 · $21
Bayer Healthcare PharmaceuticalsKerendia$19
1 payment
  • Meals for Kerendia · 2023-11-10 · $19

Professional record

NPI
1568550457
Licence
SC LL27916
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207RH0003X (207RH0003X)
Mailing address
171 Ashley Ave, Charleston, SC, 29425
NPI first listed
2006-10-10
NPI last updated
2021-12-14

This is when the NPI record was last certified, not a medical board exam.

This office lists an electronic records connection.